# EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
> **ANDA201806** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2021-10-07
## Drug
- **FDA Application Number:** ANDA201806
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Active ingredients:** EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2021-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201806)
---
*AI Analytics · CC0 1.0*